Cargando…

Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy

Background: The influence of body composition parameters in cancer prognosis attracted researchers' attention. This study investigated the role of visceral fat and skeletal muscle in the prognosis and efficacy of chemotherapy in metastatic gastric cancer (MGC). Methods: This study included MGC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Wanjing, Huang, Mingzhu, Zhao, Xiaoying, Chen, Siyuan, Wang, Chenchen, Chang, Jinjia, Guo, Weijian, Chen, Zhiyu, Zhu, Hui, Zhu, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097939/ https://www.ncbi.nlm.nih.gov/pubmed/32231736 http://dx.doi.org/10.7150/jca.37270

Ejemplares similares

Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy
por: Feng, Wanjing, et al.
Publicado: (2018)

Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
por: Zhao, Xiaoying, et al.
Publicado: (2023)

Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase II study
por: Wang, Chenchen, et al.
Publicado: (2021)

Maintenance treatment of Uracil and Tegafur (UFT) in responders following first-line fluorouracil-based chemotherapy in metastatic gastric cancer: a randomized phase II study
por: Li, Wenhua, et al.
Publicado: (2016)

A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer
por: Huang, Mingzhu, et al.
Publicado: (2021)

Oxidative Stress-Related Genetic Polymorphisms Are Associated with the Prognosis of Metastatic Gastric Cancer Patients Treated with Epirubicin, Oxaliplatin and 5-Fluorouracil Combination Chemotherapy
por: Geng, Ruixuan, et al.
Publicado: (2014)

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

Laparoscopic gastrectomy reduces adverse postoperative outcomes and decreases morbidity for gastric cancer patients with visceral obesity: a propensity score-matched analysis
por: Mao, Chenchen, et al.
Publicado: (2021)

Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen
por: Liu, Rujiao, et al.
Publicado: (2015)

A quantified risk-scoring system including the visceral fat area for peritoneal metastasis of gastric cancer
por: Chen, Xiaodong, et al.
Publicado: (2019)

FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
por: Zhang, Xiaowei, et al.
Publicado: (2022)

Is There any Role of Visceral Fat Area for Predicting Difficulty of Laparoscopic Gastrectomy for Gastric Cancer?
por: Shin, Ho-Jung, et al.
Publicado: (2015)

The Incidence of Postoperative Complications after Gastrectomy Increases in Proportion to the Amount of Preoperative Visceral Fat
por: Okada, Kazuyuki, et al.
Publicado: (2019)

Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases
por: Huang, Mingzhu, et al.
Publicado: (2022)

Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer
por: Feng, Wanjing, et al.
Publicado: (2020)

The prognostic value of age in non-metastatic gastric cancer after gastrectomy: a retrospective study in the U.S. and China
por: Zhang, Jieyun, et al.
Publicado: (2018)

Visceral fat changes after distal gastrectomy according to type of reconstruction procedure for gastric cancer
por: Tanaka, Koji, et al.
Publicado: (2013)

Prediction of the Risk of Laparoscopy-Assisted Gastrectomy by Comparing Visceral Fat Area and Body Mass Index
por: Liu, Yongke, et al.
Publicado: (2018)

Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study
por: Chang, Jinjia, et al.
Publicado: (2019)

A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
por: Kim, Jung Ho, et al.
Publicado: (2019)

High visceral fat percentage is associated with poor outcome in endometrial cancer
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
por: Li, Wenhua, et al.
Publicado: (2014)

The effect of thalidomide on visceral fat pad mass and triglyceride concentration of the skeletal muscles in rats
por: Kim, Ki-Hoon, et al.
Publicado: (2018)

Effect of visceral fat area on outcomes of laparoscopyassisted distal gastrectomy for gastric cancer: subgroup analysis by gender and parameters of obesity
por: Go, Ji-Eon, et al.
Publicado: (2015)

The effect of the visceral fat area on the predictive accuracy of C‐reactive protein for infectious complications after laparoscopy‐assisted gastrectomy
por: Iida, Michihisa, et al.
Publicado: (2020)

Visceral and subcutaneous fat
por: Lederman, Henrique Manoel
Publicado: (2014)

Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes
por: Liu, Dixing, et al.
Publicado: (2021)

Propensity score matching comparisons of postoperative complications and morbidity between digestive tract reconstruction methods after gastrectomy in gastric cancer patients with visceral obesity
por: Mao, Chenchen, et al.
Publicado: (2023)

Visceral Obesity Is a More Important Factor for Colorectal Adenomas than Skeletal Muscle or Body Fat
por: Seo, Ji Yeon, et al.
Publicado: (2022)

Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer
por: Jia, Xiya, et al.
Publicado: (2022)

Measurement of Visceral Fat: Should We Include Retroperitoneal Fat?
por: Hung, Chi-Sheng, et al.
Publicado: (2014)

Excessive visceral fat area as a risk factor for early postoperative complications of total gastrectomy for gastric cancer: a retrospective cohort study
por: Takeuchi, Masashi, et al.
Publicado: (2016)

The study of anthropometric estimates in the visceral fat of healthy individuals
por: Chen, Chun-Hao, et al.
Publicado: (2014)

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
por: Yang, Lu-Ping, et al.
Publicado: (2019)

Trajectory Analysis and Predictors of the Percentage of Body Fat Among Chinese Sleeve Gastrectomy Patients
por: Zhao, Kang, et al.
Publicado: (2021)

Figurations of Skeletal and Visceral Anatomy in the Books of Hours
por: De Voynich, Wilfrid M., et al.
Publicado: (1917)

Associations of Cognitive Function with BMI, Body Fat Mass and Visceral Fat in Young Adulthood
por: Huang, Tao, et al.
Publicado: (2019)

The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype
por: Hwang, You-Cheol, et al.
Publicado: (2016)

Skeletal muscle mass to visceral fat area ratio is an important determinant associated with type 2 diabetes and metabolic syndrome
por: Wang, Qian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_luv308jufm7prcjf4va0v6f1h6